摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-chloromethyl-2H-cycloheptafuran-2-one | 157364-77-7

中文名称
——
中文别名
——
英文名称
3-chloromethyl-2H-cycloheptafuran-2-one
英文别名
3-(Chloromethyl)cyclohepta[b]furan-2-one
3-chloromethyl-2H-cyclohepta<b>furan-2-one化学式
CAS
157364-77-7
化学式
C10H7ClO2
mdl
——
分子量
194.617
InChiKey
OIHKIGRQUGWCHS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,4-二甲氧基苄胺3-chloromethyl-2H-cycloheptafuran-2-one甲醇 为溶剂, 生成 3-[[(3,4-Dimethoxyphenyl)methylamino]methyl]cyclohepta[b]furan-2-one
    参考文献:
    名称:
    Synthesis and Analysis of Positive Inotropic Effects of 3-Substituted-2H-cyclohepta(b)furan-2-one Derivatives.
    摘要:
    合成了几种3-取代的-2H-环庚[b]呋喃-2-酮衍生物,并在体外测试了它们的正性肌力特性。在化合物8a的5-位引入异丙基,使得PIC50值(增加收缩力50%的剂量的负对数)从4.48增加到5.10。在5-异丙基-8-烷氧基化合物中,异丙氧基化合物12f具有最强的活性,PIC50值为5.99。将3-位的酯基转换为亚甲基,将8-位的烷氧基转换为取代氨基,会导致活性降低。最活跃的化合物12f,与米力农和氨力农相比,对心率(HR)增加的影响较弱。
    DOI:
    10.1248/cpb.42.865
  • 作为产物:
    描述:
    3-(甲氧羰基)-2H-环庚[b]呋喃-2-酮 在 sodium tetrahydroborate 、 氯化亚砜硫酸三氯氧磷 作用下, 以 甲醇 为溶剂, 反应 7.0h, 生成 3-chloromethyl-2H-cycloheptafuran-2-one
    参考文献:
    名称:
    Synthesis and Analysis of Positive Inotropic Effects of 3-Substituted-2H-cyclohepta(b)furan-2-one Derivatives.
    摘要:
    合成了几种3-取代的-2H-环庚[b]呋喃-2-酮衍生物,并在体外测试了它们的正性肌力特性。在化合物8a的5-位引入异丙基,使得PIC50值(增加收缩力50%的剂量的负对数)从4.48增加到5.10。在5-异丙基-8-烷氧基化合物中,异丙氧基化合物12f具有最强的活性,PIC50值为5.99。将3-位的酯基转换为亚甲基,将8-位的烷氧基转换为取代氨基,会导致活性降低。最活跃的化合物12f,与米力农和氨力农相比,对心率(HR)增加的影响较弱。
    DOI:
    10.1248/cpb.42.865
点击查看最新优质反应信息

文献信息

  • Yokota Masayuki, Yanagisawa Takashi, Kosakai Kazuhiro, Wakabayashi Shuich+, Chem. and Pharm. Bull, 42 (1994) N 4, S 865-871
    作者:Yokota Masayuki, Yanagisawa Takashi, Kosakai Kazuhiro, Wakabayashi Shuich+
    DOI:——
    日期:——
  • Synthesis and Analysis of Positive Inotropic Effects of 3-Substituted-2H-cyclohepta(b)furan-2-one Derivatives.
    作者:Masayuki YOKOTA、Takashi YANAGISAWA、Kazuhiro KOSAKAI、Shuichi WAKABAYASHI、Tsuyoshi TOMIYAMA、Masafumi YASUNAMI
    DOI:10.1248/cpb.42.865
    日期:——
    Several 3-substituted-2H-cyclohepta[b]furan-2-one derivatives were prepared and tested in vitro for positive inotropic character. Introduction of an isopropyl group at the 5-position of compound 8a caused an increase of PIC50 (negative logarithm of the dosage which increases the contractile force by 50%) from 4.48 to 5.10. Among the 5-isopropyl-8-alkoxy compounds, the isopropoxy compound 12f had the most potent activity with a PIC50 value of 5.99. Conversion of the ester group at the 3-position to a methylene group and of the alkoxy group at the 8-position to a substituted amino group caused a decrease in activity. The most active compound, 12f, was also found to have a weaker heart rate (HR)-increasing effect compared to milrinone and amrinone.
    合成了几种3-取代的-2H-环庚[b]呋喃-2-酮衍生物,并在体外测试了它们的正性肌力特性。在化合物8a的5-位引入异丙基,使得PIC50值(增加收缩力50%的剂量的负对数)从4.48增加到5.10。在5-异丙基-8-烷氧基化合物中,异丙氧基化合物12f具有最强的活性,PIC50值为5.99。将3-位的酯基转换为亚甲基,将8-位的烷氧基转换为取代氨基,会导致活性降低。最活跃的化合物12f,与米力农和氨力农相比,对心率(HR)增加的影响较弱。
查看更多

同类化合物

[2-二(2,4-二叔-丁基苯氧基)磷烷氧基-3,5-二叔-丁基-苯基]-氯-钯 N-(2-氰基乙基)-N-(2-吗啉-4-基乙基)-4-羰基-9,10-二氢-4H-苯并[4,5]环庚三烯并[1,2-b]呋喃-3-甲酰胺盐酸 N-(2-(二乙胺)乙基)-4-((2-(二乙胺)乙基)氨基)-9,10-二氢-4-羟基-4H-苯并(4,5)环庚三烯并[1,2-b]呋喃-3-甲酰胺 N,N-二乙基-4-羰基-9,10-二氢-4H-苯并[4,5]环庚三烯并[1,2-b]呋喃-3-甲酰胺 6H-2-氧杂薁-6-酮 5-甲基-2,3-二氢-7H-呋喃并[3,2-g]色烯-7-酮 5-异丙基-3-(甲氧羰基)-2H-环庚烷[b]呋喃-2-酮 3-乙酰基-2H-环庚并[b]呋喃-2-酮 3-(甲氧羰基)-2H-环庚[b]呋喃-2-酮 3,5,8-三甲基薁并[6,5-b]呋喃 2H-环戊并(b)呋喃-2-酮 2,7,8,9-四氢-6-甲基-9-亚甲基-2-氧代薁并[4,5-b]呋喃-3-甲醛 (8R)-1,5,8-三甲基-7,8-二氢-6H-薁并[7,6-D]呋喃-2-酮 (5aR,6S)-rel-(-)-5,5a,6,10-四氢-5a,6-二甲基-4H-苯并(5,6)环庚并(1,2-b)呋喃 (3R,5Z,7E)-3,25-二羟基-9,10-裂胆甾-5,7,10-三烯-23-酮 (2Z)-3-甲基-N-苯基-2H-环庚并[b]呋喃-2-亚胺 6a-isopropyl-5,6,6a,7,8,9a-hexahydro-4H-azuleno[4,5-b]furan-9-one 4-oxo-5,6,7,8-tetrahydro-4H-cyclohepta[b]furan-3-carboxylic acid 8-(2'-methoxy-2'-propyl)cycloheptafuran 8-(1'-methoxy-1'-phenylmethyl)cycloheptafuran 8-(1',1'-dimethoxymethyl)cycloheptafuran 7-acetyl-2,4-dimethyl-9,10-dimethoxyindolo[2,3-h]-1-oxazulenium perchlorate 1,3-dimethyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]furan-4-one 6-Hydroxy-1,3-dimethyl-5-trifluoroacetyl-6-trifluoromethyl-5,6,7,8-tetrahydro-4H-cycloheptenofuran-4,8-dione diethyl 2-oxo-2H-cycloheptafuran-3-ylmethylphosphonate 5,6,7,8-tetrahydro-4H-5,8-methanocyclohepta[b]furan-4-one furanoplagiochilal ethyl 4-oxo-5,6,7,8-tetrahydro-4H-cyclohepta[b]furan-3-carboxylate 6-isopropyl-2H-cycloheptafuran-2-one 3-Methylsulfonyl-5-propan-2-ylcyclohepta[b]furan-2-one 3-Methylsulfinyl-5-propan-2-ylcyclohepta[b]furan-2-one ethyl 8-methylthio-cyclohepta-furan-2-carboxylate ethyl 2-methylthio-4,5-dihydro(3H)benzocyclohepta<2,1-c>furan-9-carboxylate 3,5-dibromo-5,6,7,8-tetrahydro-2-phenyl-4H-cyclohepta[b]furan 3-bromo-2-(p-tolyl)-5,6-dihydro-4H-benzo[6,7]cyclohepta[1,2-b]furan 3-bromo-2-(3,4-dimethoxyphenyl)-5,6-dihydro-4H-benzo[6,7]cyclohepta[1,2-b]furan 5-oxatetracyclo[6.6.1.0(2,6).0(9,14)]pentadeca-2(6),3,9,11,13-pentaene-4-carbaldehyde 3-cyano-2H-cycloheptafuran-2-imine 2-furan-3-yl-3-methyl-5,6,7,8-tetrahydro-4H-cyclohepta[b]furan 2-(4-nitrophenyl)-5,6,7,8-tetrahydro-4H-cyclohepta[b]furan-6-ol 3-[(E)-1,3-dimethyl-5,6,7,8-tetrahydro-4H-cyclohepta[c]furan-4-ylidene]-4-isopropylidentetrahydrofuran-2,5-dione 6H-benzo[6,7]cyclohepta[1,2-b]furan-6-one 5,6,7,8-tetrahydro-1-butyl-4H-cycloheptafuran 5,6,7,8-tetrahydro-1-propyl-4H-cycloheptafuran 5,6,7,8-tetrahydro-1-hexyl-4H-cycloheptafuran 5,6,7,8-tetrahydro-1-heptyl-4H-cycloheptafuran 4-chloroazuleno[4,5-c]furan 3-(4-pyridinyl)-2H-cyclohepta[b]furan-2-one 1,3-bis[bis(2-oxo-2H-cyclohepta[b]furan-3-yl)methyl]benzene 3-(N-trifluoromethanesulfonyl-1,4-dihydro-4-pyridyl)-2H-cyclohepta[b]furan-2-one